New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood
SALT LAKE CITY, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and...
SALT LAKE CITY, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and...
The ongoing ARISE-HF Phase 3 global clinical trial is evaluating the efficacy of AT-001 (caficrestat) on cardiac functional capacity in...
BDC-1001 is a Boltbody™ Immune-Stimulating Antibody Conjugate (ISAC) in Phase 2 development for HER2-positive breast, colorectal, endometrial, and gastroesophageal cancersThe...
CALGARY, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX...
PITTSBURGH, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on...
BOTHELL, Wash., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing...
Proposed capital increase with preferential subscription rights, to be carried out in January 2024 to strengthen IMPLANET’s equity capital and...
FendX Technologies Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation...
Revenue of €4.3 million in the first half of 2023, +4% compared with H1 2022 Continued dynamic R&D investment coupled...
LONDON, UK / ACCESSWIRE / September 28, 2023 / Genflow (LSE:GENF) is pleased to announce its half year results for...
HALIFAX, NS / ACCESSWIRE / September 27, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) provides an update on its progress...
Calgary, Alberta--(Newsfile Corp. - September 27, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce...
SEBASTIAN, FL / ACCESSWIRE / September 27, 2023 / Addiction Helpline America, a no-cost to consumer drug and alcohol treatment...
BEVERLY HILLS, CA / ACCESSWIRE / September 26, 2023 / In a world where the intersection of aesthetics and empowerment...
Q4 2023 net revenue of $30.7 million; Adjusted EBITDA of $7.7 millionRecord Q4 2023 total prescriptions increased 32% compared to...
Findings underscore the ongoing value to the myeloma scientific community of the MMRF’s landmark molecular and clinical data and translational...
PORTSMOUTH, NH / ACCESSWIRE / September 27, 2023 / Atlantic Plastic Surgery Center is delighted to announce the expansion of...
Toronto, Ontario--(Newsfile Corp. - September 27, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (formerly ScreenPro Security Inc.) ("Justera" or the...
AVENTURA, FL / ACCESSWIRE / September 27, 2023 / Live Forever Health, a pioneer in cutting-edge health and wellness services,...
CHICAGO, IL / ACCESSWIRE / September 27, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...